| NCT ID | NCT06373679 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Cigarette Smoking |
| Study Type | INTERVENTIONAL |
| Enrollment | 225 participants |
| Start Date | 2024-07-10 |
| Primary Completion | 2027-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 225 participants in total. It began in 2024-07-10 with a primary completion date of 2027-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates whether non-cigarette tobacco products (e-cigarettes) can help smokers quit smoking as compared to traditional quit methods (nicotine replacement therapy or varenicline/Chantix). Participants in this study will be randomly assigned to one of two groups, then will have a choice between the offered products of that group. Participants in the e-cigarette group will have a choice of e-cigarette brand and flavor. Participants in the medication group will have choice between nicotine replacement therapy (patches and lozenges) or varenicline, also known as Chantix. Participation will last 6 months and will include weekly phone calls for the initial 7-weeks plus a 11-week phone call and a 6-month follow-up visit. Participants will also complete electronic daily diaries during the first 7-weeks.
Eligibility Criteria
Inclusion Criteria * Adults 21+ who previously had a quit attempt using FDA-approved pharmacotherapy. * Interest in reducing harms from tobacco use or quitting smoking Exclusion Criteria * Pregnant, breastfeeding, or trying to become pregnant. * Household member currently enrolled in the study * Planning to move out of the area within the next 7 months
Contact & Investigator
Tracy Smith
PRINCIPAL INVESTIGATOR
smithtra@musc.edu
Frequently Asked Questions
Who can join the NCT06373679 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Cigarette Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06373679 currently recruiting?
Yes, NCT06373679 is actively recruiting participants. Contact the research team at smithtra@musc.edu for enrollment information.
Where is the NCT06373679 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT06373679 clinical trial?
NCT06373679 is sponsored by Medical University of South Carolina. The principal investigator is Tracy Smith at smithtra@musc.edu. The trial plans to enroll 225 participants.